Dexcom Stelo is an FDA-cleared over-the-counter continuous glucose monitor for adults 18 and older who do not use insulin. Dexcom launched Stelo in March 2024 to bring continuous real-time glucose monitoring to non-diabetic adults without a prescription or any clinical visit required.

Stelo uses a small upper-arm sensor that lasts 15 days and streams live glucose data to the free Stelo app via Bluetooth. Users see real-time glucose values, trend arrows, and weekly pattern reports. Abbott Lingo is the primary OTC alternative. Stelo costs $89 per month on subscription, with no prescription needed at any major retailer.

This review covers how the Stelo sensor and app work, what verified users report about the real experience, how accuracy and features compare to Abbott Lingo, what the device costs without insurance, and whether the subscription price genuinely justifies itself for a non-insulin adult.

What Is the Dexcom Stelo Glucose Biosensor?

Dexcom Stelo is an over-the-counter (OTC) integrated continuous glucose monitor (iCGM) cleared by the FDA in 2024 for adults 18 and older who do not use insulin. This makes Stelo the first CGM in history approved for direct purchase without a prescription. Dexcom, with over 25 years of glucose sensing technology leadership, built Stelo to bring professional-grade glucose monitoring to the general public. The system tracks glucose continuously, 24 hours a day, and sends data to a free smartphone app.

The Stelo system has three components: an all-in-one sensor and transmitter placed using a spring-loaded applicator, an adhesive overpatch for secure skin attachment, and the free Stelo app available on iOS and Android. Each component works together. The sensor sits just under the skin of the upper arm. The transmitter streams live glucose data to the phone via Bluetooth.

Stelo is part of Dexcom’s broader CGM product line. The Dexcom G7 and G7 15 Day are the company’s prescription CGM systems, used by people with Type 1 and Type 2 diabetes who manage glucose with insulin. In fact, Stelo serves a completely different population. It targets the estimated 100+ million US adults who want glucose insight but have never qualified for, or been able to access, a prescription CGM device.

Who Is the Dexcom Stelo Designed For?

Dexcom Stelo targets adults 18 and older who do not use insulin, including people with Type 2 diabetes managed through diet and oral medications, adults with prediabetes, and health-focused individuals who want to understand how food, exercise, and sleep affect their metabolic health. These users benefit from glucose insight without needing a prescription or a diabetes diagnosis.

Stelo is not for people who take insulin. Type 1 diabetics and insulin-dependent Type 2 diabetics need a prescription CGM with alarm capabilities for safe glucose management. Stelo does not alert users when glucose drops to dangerous levels. This is a deliberate design choice for a population that is not at risk of medication-induced hypoglycemia.

Who Stelo Is For vs. Who It Is Not:

Adults 18+ with Type 2 diabetes managed by diet or oral medications
Adults with prediabetes seeking lifestyle guidance
Health-curious adults tracking metabolic wellness
Not for Type 1 diabetics
Not for insulin-dependent Type 2 diabetics
Not for anyone at risk of hypoglycemia

How Does Stelo Differ from Prescription CGMs?

Dexcom Stelo differs from prescription CGMs in that it requires no doctor’s visit, no insurance authorization, and no formal diabetes diagnosis to purchase. This opens continuous glucose monitoring to the general adult public for the first time. Prescription devices like the Dexcom G7 require written authorization from a healthcare provider. Stelo is sold directly off the shelf at pharmacies and online retailers nationwide.

Here’s the key difference. Prescription CGMs include urgent low glucose alarms and integrate with insulin pumps for automated dosing decisions. Stelo omits both features by design. Why? Because its users don’t take insulin. There’s no need for a hypoglycemia alarm when the device is never used to guide a medication dose. The device does not alert users when glucose drops to dangerous levels. This is not a flaw. It reflects Stelo’s intended use in a non-insulin population where hypoglycemia risk is low.

Cost structure also differs. Prescription CGMs are often covered by health insurance for qualifying patients, sometimes at no out-of-pocket cost. Stelo is an OTC device with no standard insurance reimbursement pathway. Users pay the full retail price directly. FSA and HSA accounts may accept Stelo as an eligible medical expense, but standard health insurance does not cover it.

How Does the Dexcom Stelo Work?

Dexcom Stelo works by inserting a thin, flexible wire sensor just beneath the skin of the upper arm, where it continuously measures glucose levels in the interstitial fluid that surrounds tissue cells and closely mirrors blood glucose levels. The sensor uses electrochemical detection to generate a glucose reading. These readings update continuously throughout the day and night without any user action required.

The transmitter is the electronic component that sits on the skin surface, positioned directly above the inserted sensor wire. It processes the incoming glucose signal and streams data to the Stelo app via Bluetooth Low Energy. The transmitter and sensor ship as one integrated unit and are discarded together when the sensor expires.

The Stelo app receives glucose values and displays the current reading alongside a trend arrow. The arrow shows whether glucose is rising rapidly, rising slowly, stable, falling slowly, or falling rapidly. This directional context is more useful than a raw number alone. Not just where glucose is right now, but where it’s heading. That’s what trend arrows give you.

How Do You Insert the Stelo Sensor?

The Stelo applicator inserts the sensor with a single click. A spring-loaded mechanism places the thin wire under the skin of the upper arm automatically. The user never sees the needle at any point during the process. The applicator retracts immediately after the click. Most users describe the sensation as a brief pinch, and many report feeling nothing at all during insertion.

The recommended placement site is the back of the upper arm. The sensor is secured to the skin with the built-in adhesive patch. An additional overpatch is included in the kit to reinforce adhesion during physical activity, swimming, or sweating. Proper placement reduces the risk of the sensor shifting or detaching during the full 15-day wear period.

Stelo Sensor Insertion Steps:

Clean and dry the back of the upper arm
Remove the applicator from the sealed packaging
Press the applicator firmly against the skin and click the activation button
Apply the adhesive overpatch over the sensor body
Open the Stelo app and pair the new sensor via Bluetooth
Wait 30 minutes for the warmup period to complete before trusting readings

How Does Stelo Send Glucose Data to Your Phone?

Stelo’s transmitter streams glucose readings to the Stelo app via Bluetooth Low Energy, with updated values arriving on a paired iOS or Android smartphone every few minutes. The phone must stay within standard Bluetooth range to maintain this live connection. The connection runs continuously in the background. Users see their current glucose value and trend arrow on the phone’s lock screen or within the open app at any time.

The Stelo app stores up to 90 days of glucose history. Want to see what happened last Tuesday at lunch? Users can view charts covering the past 1, 3, 6, or 12 hours, or zoom out to see full weekly trends. The pattern view helps identify which meals, activities, or sleep patterns cause the largest or most sustained glucose responses across multiple days.

What’s more, Stelo integrates with the Oura Ring app. Users who own both devices can view glucose readings alongside sleep scores, heart rate variability, and daily activity metrics in a single overlay. This combination provides a more complete metabolic picture than either device delivers alone. The integration is configured directly within the Oura app settings.

What Are the Key Features of Dexcom Stelo?

Dexcom Stelo offers 15-day continuous wear, no-calibration operation, Bluetooth data transmission, and a free companion app on iOS and Android, all available without a prescription, insurance approval, or any clinical interaction required. The design prioritizes simplicity. Users apply the sensor, pair the app, and begin receiving glucose data within 30 minutes of completing setup.

And it goes beyond raw numbers. The Stelo app includes spike detection, pattern analysis, meal logging, and in-app educational content. The weekly summary report shows average glucose levels, time-in-range percentages, and notable glucose spikes tied to specific meals or activities. These insights help users make a direct connection between daily choices and measurable glucose outcomes.

Stelo is also waterproof. The sensor withstands submersion to 8 feet (2.4 meters) for up to 24 hours continuously. Users can swim, shower, and bathe without removing or protecting the sensor. This waterproofing applies across the full 15-day wear period.

Dexcom Stelo Key Specifications:

Specification	Value
Sensor wear time	Up to 15 days (+ 12-hour grace period)
Sensor size	24.14 mm (W) x 27.4 mm (L) x 4.72 mm (H)
Warmup time	30 minutes
Water resistance	8 feet (2.4 m) for up to 24 hours
Data transmission	Bluetooth Low Energy
App compatibility	iOS and Android
Calibration required	No
Prescription required	No

How Long Does the Stelo Sensor Last?

Each Stelo sensor lasts up to 15 days with an additional 12-hour grace period. This grace period extends total possible wear to 15.5 days before the transmitter stops sending data. Users gain extra time to prepare a replacement before monitoring stops. No scramble. No gap in your data. The 2-pack sold at retail covers approximately 30 days of continuous glucose tracking. The Stelo app notifies users when the current sensor is approaching its expiration date.

When the sensor expires, users discard the all-in-one sensor and transmitter unit and apply a fresh sensor to continue monitoring without interruption. Replacement sensors must be purchased separately unless the user is enrolled in a subscription plan, which auto-ships new sensors before the current pair runs out.

Stelo’s 15-day sensor lifespan matches the longest OTC glucose sensor currently on the market. Abbott Lingo sensors last 14 days per unit. The Dexcom G7 15 Day prescription system also offers 15-day wear, but it requires a prescription and targets insulin users. On wear duration alone, Stelo offers the longest continuous OTC coverage available.

What apps work with Dexcom Stelo? Here’s what you need to know:

The Stelo app is available for free on iOS devices running iOS 15 or newer (iPhone 8 or later) and on select Android smartphones via the Google Play Store, with no additional subscription cost beyond the sensor purchase price. The app is the only interface for viewing Stelo glucose data. Bluetooth must remain active on the paired phone during use to maintain the live data connection.

Stelo integrates with the Oura Ring app. Oura users who also wear Stelo can overlay their glucose readings with sleep quality scores, heart rate variability, and daily activity metrics in the Oura interface. This is the most significant third-party compatibility Stelo currently offers and one of its strongest differentiators from Abbott Lingo.

The Stelo app does not connect to Apple Health, Samsung Health, or Google Fit as of 2025. Users who consolidate health data in these ecosystems cannot sync Stelo data automatically. This gap is among the most commonly cited limitations in user reviews. Dexcom has not announced additional platform integrations at this time.

What Are the Benefits of Dexcom Stelo?

Dexcom Stelo provides real-time visibility into how food, exercise, and sleep affect blood glucose levels. Users gain concrete metabolic data to support healthier daily decisions without a medical diagnosis or prescription. Before OTC CGMs like Stelo existed, this type of continuous glucose insight was restricted to people with a formal diabetes diagnosis and a doctor’s written order. That barrier is now gone for non-insulin adults.

Users commonly modify eating habits after seeing which specific foods trigger their sharpest glucose spikes. A meal that looks healthy on paper may cause a significant glucose rise in one person and a minimal response in another. Sound surprising? Stelo reveals this individual variation. This is the kind of data that nutritional advice can never personalize for a specific person. No generalized dietary guideline can replicate what personal glucose data shows about a specific person’s metabolic response.

Stelo also eliminates the prescription barrier that previously kept non-diabetic adults from accessing CGM technology. People with prediabetes, a family history of diabetes, or general health goals can now use the same sensor technology as medical CGM patients. This accessibility shift has real downstream implications. Dexcom estimates that more than 100 million US adults could benefit from this kind of glucose insight.

Key Benefits of Dexcom Stelo:

Real-time glucose tracking 24/7 without a prescription
Reveals individual food-glucose responses that general guidelines miss
Motivates lower-glycemic food choices by making spikes visible
Accessible to prediabetics and health-focused adults for the first time
Removes the prescription barrier that blocked non-diabetic CGM access

Does Stelo Help with Weight Loss?

Yes. Stelo helps users identify which specific foods and meal patterns cause large glucose spikes, and this real-time visibility often motivates lower-glycemic food choices that support weight management goals by reducing the insulin spikes linked to fat storage and post-meal hunger. Seeing the mechanism play out on a live chart gives users a concrete behavioral lever that general nutrition advice cannot provide.

High-glycemic foods cause rapid glucose rises followed by sharp drops. What happens after those drops? They trigger hunger signals and often lead to overeating within two to three hours. Stelo users can observe this pattern in their own data and experiment with meal timing, food swaps, and portion adjustments to flatten their personal glucose curve. Flatter curves are associated with reduced hunger and more stable energy throughout the day.

Stelo does not directly cause weight loss. Here’s the thing: it’s an awareness tool, not a treatment. Users who engage with the data and make behavioral adjustments based on what they see may achieve meaningful improvements in eating patterns. Passive use, wearing the sensor without modifying any habits, is unlikely to produce measurable weight change on its own.

Can Stelo Help You Build Healthier Habits?

Yes. Stelo creates a direct feedback loop between daily behaviors and glucose outcomes. In real time, users see how meals, movement, and sleep quality alter their metabolic state. Annual lab tests and general health advice never could demonstrate these effects at an individual level. This is the fundamental advantage of continuous monitoring. This tight feedback compresses the habit-change cycle. Users see cause and effect within hours rather than waiting months for blood test results to shift.

The Stelo app identifies recurring glucose patterns in weekly reports. A user who consistently spikes after pasta but not after a similar-calorie salad can act on that specific finding. Pattern recognition replaces trial-and-error guessing. The data provides a level of personal dietary specificity that no population-level dietary guideline can match.

Users across multiple review platforms report walking more after meals, reducing late-night snacking, and improving sleep consistency after one to two months of tracking with Stelo. These behavioral changes are driven directly by seeing glucose consequences in real time. Bottom line: Stelo works as a behavioral mirror. It doesn’t make decisions for users, but it makes the outcomes of their decisions clearly visible.

What Do Dexcom Stelo Reviews Say?

Dexcom Stelo reviews are generally positive overall, with users praising the painless sensor application, reliable glucose readings, and the value of accessing real-time metabolic data for the first time without needing a prescription or a doctor’s appointment. Most reviewers agree that Stelo delivers on its core promise: continuous glucose visibility that reveals patterns a fingerstick meter could never show.

The most praised feature is ease of setup. Users consistently report going from unboxing to first glucose reading in under 30 minutes. Here’s the good news: sensor insertion is described as painless by the majority of reviewers. The Stelo app earns consistent praise for its clean interface, informative trend arrows, and the usefulness of its weekly pattern summaries.

Critical reviews center on three recurring issues: sensor adhesion failures during heavy physical activity, limited third-party app integration, and the absence of configurable low glucose alerts. These limitations are by design for a non-insulin population, but some users find them frustrating, particularly those who expected Stelo to behave more like a prescription CGM.

What Do Positive Stelo Reviews Highlight?

Positive Stelo reviews consistently highlight three core benefits: the painless sensor insertion, accurate readings that closely match fingerstick blood glucose values, and the educational impact of watching real-time glucose responses to food and exercise for the first time. Many reviewers describe Stelo as the first health tracking device that actually changed how they think about eating, not just what they track.

Reviewers with prediabetes frequently credit Stelo with helping them understand their metabolic state for the first time without a clinical visit. Can a CGM actually help reduce A1C? Several verified users report exactly that. They cite A1C reductions after two to three months of using Stelo data to guide dietary adjustments. The device’s OTC availability is cited repeatedly as the factor that made access possible when it wasn’t before.

The Stelo app earns 4.3 out of 5 stars on the Apple App Store and 4.2 out of 5 stars on Google Play as of 2025. Users specifically praise the weekly summary design, the clarity of the trend arrow, and the Oura Ring integration as the standout features that separate Stelo from basic glucose trackers.

What Are the Common Stelo Complaints?

The most common Stelo complaint involves sensor adhesion, with users reporting that the patch lifts or detaches during heavy exercise, swimming, or prolonged exposure to heat and humidity, even when the included overpatch is applied correctly from the start. To be clear, Dexcom includes one overpatch per sensor, but reviews suggest this is insufficient for highly active users. Applying a third-party waterproof patch over the overpatch improves adhesion for most active wearers.

The second recurring complaint is the absence of configurable glucose alerts. Some users with prediabetes and Type 2 diabetes want the option to receive a notification when glucose drops below a threshold they choose. Stelo offers no configurable alarms of any kind. This limitation is non-negotiable for anyone who wants proactive low-glucose warnings from their CGM device.

The Stelo app’s lack of integration with Apple Health, Samsung Health, and Google Fit frustrates users who consolidate health metrics in these ecosystems. Manual data entry is the only available workaround. Several reviewers flag this as a significant quality-of-life gap, especially when comparing Stelo to other wearables that sync automatically with these major health platforms.

Dexcom Stelo vs Abbott Lingo: Which Is Better?

Dexcom Stelo and Abbott Lingo are the two primary over-the-counter continuous glucose monitors available without a prescription in the United States, both launched in 2024 with nearly identical pricing but fundamentally different approaches to how they present glucose data to users. Both target non-insulin adults. Both require no doctor’s visit. The decision comes down to one key question: does the user want raw clinical glucose values, or a gamified scoring system built around simplification?

On sensor specs, Stelo holds a slight edge. Does one extra day matter? For users who want to minimize sensor changes, yes. Stelo sensors last 15 days per unit. Lingo sensors last 14 days. Both are waterproof and worn on the upper arm. Neither requires calibration. In terms of core sensor function, the two products perform very similarly for the daily user.

Pricing is nearly identical for ongoing users. A Stelo monthly subscription costs $89 (USD) for a 2-pack. Abbott Lingo sensors cost approximately $49 each. Two sensors cover the same 30-day period, which brings the monthly Lingo cost to approximately $98 (USD). Stelo’s subscription pricing undercuts Lingo by about $9 per month, roughly a 9% cost advantage at the subscription rate.

Dexcom Stelo vs Abbott Lingo at a Glance:

Feature	Dexcom Stelo	Abbott Lingo
Sensor wear time	15 days	14 days
Accuracy (MARD)	~8.6%	~7.9%
Monthly cost (2 sensors)	$89 USD (subscription)	~$98 USD
App data format	Raw mg/dL glucose values	‘Lingo Count’ points system
Prescription required	No	No
Oura Ring integration	Yes	No
Apple Health sync	No	No

How Does Stelo Compare to Abbott Lingo in Accuracy?

Stelo’s accuracy is rated at a mean absolute relative difference (MARD) of approximately 8.6%, the primary clinical metric used by the FDA to evaluate CGM sensor accuracy, and this figure falls within the FDA’s approved threshold for an over-the-counter iCGM device. Abbott Lingo reports a MARD of approximately 7.9%, giving Lingo a marginal accuracy advantage in the clinical submission data each company provided to the FDA for OTC clearance.

In practice, MARD differences below 1 to 2% rarely produce noticeable differences in daily glucose readings. Both sensors measure the same interstitial glucose. A sensor placed correctly on a well-perfused area of the upper arm, with proper adhesion and no local tissue trauma, tends to perform close to its stated MARD. Placement quality, hydration level, and body temperature all influence real-world accuracy more than a 0.7% MARD gap between two OTC devices.

Independent head-to-head accuracy testing between Stelo and Lingo in real-world conditions is limited as of 2025. Most available accuracy data comes from each manufacturer’s separate FDA clearance submissions. Users who have worn both devices report that each delivers consistent, believable readings compared to simultaneous fingerstick blood glucose measurements taken as a reference.

Which App Offers Better Insights, Stelo or Lingo?

The Stelo app displays glucose values in mg/dL alongside trend arrows and weekly pattern reports, matching the clinical CGM data format that healthcare providers use, which suits users who want raw glucose numbers and direct pattern analysis without translation into a proprietary metric. The Lingo app converts glucose into a ‘Lingo Count’ daily score, a gamified system designed for users with no prior CGM experience. Stelo suits clinically-minded users. Lingo suits those who find raw glucose values intimidating or confusing.

Stelo’s integration with the Oura Ring provides a meaningful advantage for users who already own that wearable. Overlaying glucose data with sleep scores, activity rings, and heart rate variability creates a more complete metabolic picture. Lingo does not offer a comparable third-party health platform integration at this time. This gives Stelo a real usability edge for the growing segment of Oura users.

Both apps include educational content about glucose management and lifestyle. Stelo’s in-app content focuses on evidence-based lifestyle strategies tied to glucose data: meal composition, exercise timing, and sleep quality. Lingo’s coaching content is structured around its points-based framework. Users who already understand glucose physiology, or who want to learn it, consistently prefer Stelo’s direct clinical data approach.

Is Dexcom Stelo Safe to Use?

Yes. Dexcom Stelo is FDA-cleared for OTC use, having met the FDA’s safety and effectiveness requirements for a non-prescription integrated continuous glucose monitor in March 2024. Stelo is one of the first devices of its kind ever approved for direct consumer purchase in the United States. When used according to the labeling instructions, Stelo does not pose known risks to adults 18 and older who do not use insulin, which is its FDA-cleared target population.

Stelo Safety Rules to Know:

Remove the sensor before any MRI or CT scan (MR Unsafe classification)
Do not use Stelo to calculate or adjust insulin doses
Not approved for people who take insulin of any kind
Inform all medical staff about the worn sensor before imaging procedures

Is there anything to watch out for? Yes. Stelo is classified as MR Unsafe. The transmitter must be removed before any MRI or CT scan procedure. Wearing the device inside an MRI poses a risk of transmitter heating or movement caused by the magnetic field. Users must inform medical and imaging staff about the worn sensor before any diagnostic imaging appointment.

Stelo must not be used to guide insulin dosing. The device is approved only for people who do not take insulin. Using Stelo readings to calculate or adjust insulin doses falls outside its FDA-cleared indication. Doing so could result in dangerous and potentially life-threatening dosing errors. The product labeling explicitly states users should not take medical action based on Stelo data without consulting a qualified healthcare professional.

What Side Effects Does Stelo Cause?

The most common Stelo side effects involve the skin at the insertion and adhesion site, including localized redness, mild itching, and irritation caused by the sensor adhesive and overpatch pressing against the skin continuously for up to 15 days. These reactions are typically mild and resolve within a few days of removing the sensor. They occur more frequently in users with sensitive skin or known adhesive allergies.

Sensor insertion causes a brief pinch for most users. Some report minimal discomfort. Others feel nothing at all. A small bruise may develop at the insertion point and typically fades within one to two days of insertion. Pain, significant swelling, or persistent warmth at the insertion site beyond 48 hours warrants removing the sensor and consulting a healthcare provider.

Users with nickel sensitivity, latex allergies, or a history of contact dermatitis should review the sensor material specifications in the Stelo product labeling before first use. Dexcom recommends stopping use and seeking medical advice if a significant skin reaction develops during the wear period. No systemic side effects from the sensor electronics or adhesive materials have been reported in clinical use under FDA-cleared conditions.

How Much Does Dexcom Stelo Cost?

Dexcom Stelo costs $99 (USD) for a one-time 2-pack purchase, or $89 per month on a monthly subscription plan, both options providing two 15-day sensors that cover approximately 30 days of continuous glucose monitoring with no prescription or insurance requirement. Extended subscription commitments reduce the monthly cost further. A 3-month subscription brings the rate to approximately $82 per month. A 6-month plan offers additional per-month savings.

Dexcom Stelo Pricing Options:

Plan	Price (USD)	Cost per Day
One-time 2-pack	$99	~$3.30/day
Monthly subscription (2-pack)	$89/month	~$2.97/day
3-month subscription	~$82/month	~$2.73/day
Abbott Lingo (2 sensors, 28 days)	~$98/month	~$3.50/day

Here’s the catch. Health insurance does not typically cover Stelo because it is sold as an OTC device without a prescription pathway. This is the primary cost disadvantage compared to prescription CGMs, which qualifying patients can often receive at little or no out-of-pocket cost through insurance. Stelo is eligible for FSA and HSA account reimbursement at most plan administrators. Users should confirm FSA or HSA eligibility with their plan provider before purchasing.

On a per-day basis, the subscription plan costs approximately $2.97 (USD) per day. The one-time purchase costs approximately $3.30 per day. For comparison, Abbott Lingo sensors cost $49 each for a 14-day wear period. That works out to approximately $3.50 (USD) per day. Stelo’s subscription pricing undercuts Lingo’s daily cost by roughly 15%.

Is Dexcom Stelo Worth the Price?

Yes. Dexcom Stelo delivers approximately 2,000 or more individual glucose readings per sensor over 15 days, which at the $89 subscription price equals roughly $0.04 to $0.05 (USD) per reading, a cost-per-data-point that no fingerstick glucose testing method can match at the scale of continuous monitoring. A traditional fingerstick test strip costs $0.15 to $0.50 (USD) per single reading. Stelo delivers thousands of contextual readings for the same or lower total cost.

The good news? The $89 per month subscription is comparable in price to many common health investments: gym memberships, nutrition coaching apps, and premium fitness wearables. Users who use Stelo to modify diet, improve sleep, or add post-meal walks may achieve health improvements that extend well beyond the sensor’s 15-day wear period and generate health value that justifies the ongoing monthly cost.

Here’s the honest bottom line: Stelo’s value is highest for users who actively engage with the data and experiment with lifestyle adjustments across multiple sensor cycles. Passive use, wearing it without changing any habits, is unlikely to return meaningful value at this price point. The device is a mirror. Its return depends entirely on what the user does with what it reflects.

Is Dexcom Stelo Worth It?

Yes. Dexcom Stelo is worth it for adults not on insulin who want to understand how food, exercise, and sleep affect their glucose and are motivated to act on that data over at least 30 to 60 days of consistent, engaged use. For prediabetics, Type 2 diabetics managing with diet and oral medications, and health-curious adults, Stelo delivers continuous glucose insight at a price no fingerstick device can replicate. The value lies in the pattern recognition across days and weeks, not in any single glucose number.

To be clear, Stelo is not worth it for anyone who needs insulin management tools, customizable low-glucose alarms, or insurance reimbursement. Type 1 diabetics and insulin-dependent Type 2 diabetics need a prescription CGM with alarm functionality and insulin dosing support. Stelo’s OTC positioning is both its defining advantage and its hard limit for this population.

The strongest Stelo use case is a motivated adult who recently received a prediabetes diagnosis or has a strong family history of diabetes, wants to make diet and exercise changes before medication becomes necessary, and is willing to commit to reviewing glucose data and making incremental behavioral adjustments across multiple sensor cycles. That person is the user Stelo was built for.

Where Can You Buy Dexcom Stelo?

Dexcom Stelo is available without a prescription at major US pharmacy chains and retail stores including CVS, Walgreens, Target, Walmart, and Sam’s Club, as well as on Amazon with Prime shipping options and through the official Dexcom website at Dexcom.com with subscription pricing. No insurance referral or doctor’s note is required at the point of purchase. The sensor ships in standard consumer packaging and is available over the counter in the pharmacy health section at most major chains.

And for ongoing users, the Dexcom website offers the best pricing through its subscription plans. The monthly subscription at $89 (USD) auto-ships a fresh 2-pack before the current sensor pair expires. Longer subscription commitments at 3-month and 6-month intervals reduce the monthly rate further and eliminate the need to manually reorder each month.

Amazon carries Stelo at approximately $99 (USD) per 2-pack for one-time purchases with Prime shipping. Retail prices at pharmacy and grocery chains may vary by location. International availability is limited. Stelo’s OTC classification is specific to the United States regulatory framework as of 2025. The device is not available without a prescription in most other countries at this time.

Dexcom Stelo Glucose Biosensor Review: Is It Worth It?